# US 2021/0071209 A1 · Biosynthesis of cannabinoids and cannabinoid precursors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0071209 A1
- Document ID: US20210071209A1
- Status: Published application
- Kind: A1
- Application number: 17/078,872
- Filed: 2020-10-23
- Published: 2021-03-11
- Earliest claimed: 2019-02-25
- Assignees: Ginkgo Bioworks, Inc.
- Applicants: Ginkgo Bioworks, Inc.
- Inventors: Kim Cecelia Anderson; Elena Brevnova; Dylan Alexander Carlin; Brian Carvalho; Nicholas Flores; Katrina Forrest; Matthew McMahon; Massimo Merighi; Gabriel Rodriguez; Emily E. Wrenbeck
- Web page: https://patentgrep.com/patent/US20210071209A1

## CPC

- C12P 7/22: aromatic
- C12M 41/30: {of concentration}
- C12N 1/16: Yeasts; Culture media therefor
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 9/1085: {transferring alkyl or aryl groups other than methyl groups (2.5)}
- C12N 9/88: Lyases (4.)
- C12N 9/93: {Ligases (6)}
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12N 15/81: for yeasts
- C12P 7/42: Hydroxy-carboxylic acids
- C12P 17/06: containing a six-membered hetero ring, e.g. fluorescein
- C07K 2319/41: containing a Myc-tag
- C12N 1/185: Saccharomyces isolates
- C12R 2001/865: Saccharomyces cerevisiae
- C12Y 101/01034: Hydroxymethylglutaryl-CoA reductase (NADPH) (1.1.1.34)
- C12Y 121/03007: Tetrahydrocannabinolic acid synthase (1.21.3.7)
- C12Y 121/03008: Cannabidiolic acid synthase (1.21.3.8)
- C12Y 203/0102: Diacylglycerol O-acyltransferase (2.3.1.20)
- C12Y 203/01026: Sterol O-acyltransferase (2.3.1.26)
- G01N 33/487: of liquid biological material
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12Y: ENZYMES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Aspects of the disclosure relate to biosynthesis of cannabinoids and cannabinoid precursors in recombinant cells and in vitro.

## Claims

### Claim at position 1

1-71. (canceled)

### Claim 72

A method for producing a cannabinoid or cannabinoid precursor comprising culturing a host cell that comprises a heterologous polynucleotide encoding a polyketide synthase (PKS), wherein the PKS comprises a sequence that is at least 95% identical to SEQ ID NO: 7.

### Claim 73 (depends on 72)

The method of claim 72, wherein relative to the sequence of SEQ ID NO: 7, the PKS comprises an amino acid substitution at a residue corresponding to position 28, 34, 50, 70, 71, 76, 88, 100, 151, 203, 219, 285, 359, and/or 385 in SEQ ID NO: 7.

### Claim 74 (depends on 72)

The method of claim 72, wherein the PKS comprises:
a) the amino acid P at a residue corresponding to position 28 in SEQ ID NO: 7;
b) the amino acid Q at a residue corresponding to position 34 in SEQ ID NO: 7;
c) the amino acid N at a residue corresponding to position 50 in SEQ ID NO: 7;
d) the amino acid M at a residue corresponding to position 70 in SEQ ID NO: 7;
e) the amino acid Y at a residue corresponding to position 71 in SEQ ID NO: 7;
f) the amino acid I at a residue corresponding to position 76 in SEQ ID NO: 7;
g) the amino acid A at a residue corresponding to position 88 in SEQ ID NO: 7;
h) the amino acid P or T at a residue corresponding to position 100 in SEQ ID NO: 7;
i) the amino acid P at a residue corresponding to position 151 in SEQ ID NO: 7;
j) the amino acid K at a residue corresponding to position 203 in SEQ ID NO: 7;
k) the amino acid C at a residue corresponding to position 219 in SEQ ID NO: 7;
l) the amino acid A at a residue corresponding to position 285 in SEQ ID NO: 7;
m) the amino acid M at a residue corresponding to position 359 in SEQ ID NO: 7; and/or
n) the amino acid M at a residue corresponding to position 385 in SEQ ID NO: 7.

### Claim 75 (depends on 72)

The method of claim 72, wherein the PKS comprises one or more of the following amino acid substitutions relative to SEQ ID NO: 7: V71Y and F70M.

### Claim 76 (depends on 72)

The method of claim 72, wherein the PKS comprises:
a) C at a residue corresponding to position 164 in SEQ ID NO: 7;
b) H at a residue corresponding to position 304 in SEQ ID NO: 7; and/or
c) N at a residue corresponding to position 337 in SEQ ID NO: 7.

### Claim 77 (depends on 72)

The method of claim 72, wherein the PKS comprises SEQ ID NO: 7.

### Claim 78 (depends on 72)

The method of claim 72, wherein the host cell is capable of producing 3,5,7-trioxododecanoyl-CoA, olivetol, and/or olivetolic acid.

### Claim 79 (depends on 78)

The method of claim 78, wherein the host cell is capable of producing more 3,5,7-trioxododecanoyl-CoA, olivetol, and/or olivetolic acid than a host cell that expresses a PKS that comprises SEQ ID NO: 5.

### Claim 80 (depends on 72)

The method of claim 72, wherein the heterologous polynucleotide comprises a sequence that is at least 95% identical to SEQ ID NO: 38 or 176.

### Claim 81 (depends on 72)

The method of claim 72, wherein the host cell is a yeast cell.

### Claim 82 (depends on 81)

The method of claim 81, wherein the yeast cell is a Saccharomyces cell, a Yarrowia cell, a Pichia cell or a Komagataella cell.

### Claim 83 (depends on 82)

The method of claim 82, wherein the Saccharomyces cell is a Saccharomyces cerevisiae cell.

### Claim 84 (depends on 72)

The method of claim 72, wherein the host cell further comprises one or more heterologous polynucleotides encoding one or more of: an acyl activating enzyme (AAE), a polyketide cyclase (PKC), a prenyltransferase (PT), and/or a terminal synthase (TS).

### Claim 85

A method for producing a cannabinoid or cannabinoid precursor comprising culturing a host cell that comprises a heterologous polynucleotide encoding a polyketide synthase (PKS), wherein the PKS comprises SEQ ID NO: 7 or a conservatively substituted version thereof.

### Claim 86 (depends on 85)

The method of claim 85, wherein the host cell is capable of producing 3,5,7-trioxododecanoyl-CoA, olivetol, and/or olivetolic acid.

### Claim 87 (depends on 86)

The method of claim 86, wherein the host cell produces more 3,5,7-trioxododecanoyl-CoA, olivetol, and/or olivetolic acid than a host cell that expresses a PKS that comprises SEQ ID NO: 5.

### Claim 88 (depends on 85)

The method of claim 85, wherein the host cell is a yeast cell.

### Claim 89 (depends on 88)

The method of claim 88, wherein the yeast cell is a Saccharomyces cell, a Yarrowia cell, a Pichia cell or a Komagataella cell.

### Claim 90 (depends on 89)

The method of claim 89, wherein the Saccharomyces cell is a Saccharomyces cerevisiae cell.

### Claim 91 (depends on 85)

The method of claim 85, wherein the host cell further comprises one or more heterologous polynucleotides encoding one or more of: an acyl activating enzyme (AAE), a polyketide cyclase (PKC), a prenyltransferase (PT), and/or a terminal synthase (TS).

### Claim 92

A yeast cell for producing a cannabinoid or a cannabinoid precursor that comprises a heterologous polynucleotide encoding a polyketide synthase (PKS), wherein the PKS comprises a sequence that is at least 95% identical to SEQ ID NO: 7 or wherein the PKS comprises a conservatively substituted version of SEQ ID NO: 7.

### Claim 93 (depends on 92)

The yeast cell of claim 92, wherein the yeast cell is a Saccharomyces cell, a Yarrowia cell, a Pichia cell or a Komagataella cell.

### Claim 94 (depends on 93)

The yeast cell of claim 93, wherein the Saccharomyces cell is a Saccharomyces cerevisiae cell.

### Claim 95

A bioreactor for producing a cannabinoid or a cannabinoid precursor containing:
a. malonyl-CoA;
b. an optionally substituted alkanoic acid; and
c. a polyketide synthase (PKS) comprising an amino acid sequence that is at least 95% identical to SEQ ID NO: 7.

### Claim 96 (depends on 95)

The bioreactor of claim 95, further comprising an acyl activating enzyme (AAE), a polyketide cyclase (PKC), a prenyltransferase (PT), and/or a terminal synthase (TS).
